Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$ 632	$ 504
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(114)	(27)
Purchases of property and equipment	(407)	(474)
Proceeds from disposition of hospitals and other ancillary operations	12	62
Proceeds from sale of property and equipment	7	11
Purchases of available-for-sale securities	(63)	(90)
Proceeds from sales of available-for-sale securities	233	86
Proceeds from the sale of investments in unconsolidated affiliates	403
Distribution from Quorum Health Corporation	1,219
Increase in other investments	(113)	(80)
Net cash provided by (used in) investing activities	1,177	(512)
Cash flows from financing activities:
Proceeds from exercise of stock options		22
Repurchase of restricted stock shares for payroll tax withholding requirements	(5)	(20)
Deferred financing costs and other debt-related costs	(22)	(30)
Redemption of noncontrolling investments in joint ventures	(16)	(14)
Distributions to noncontrolling investors in joint ventures	(47)	(48)
Borrowings under credit agreements	2,806	2,385
Proceeds from receivables facility	31	91
Repayments of long-term indebtedness	(4,279)	(2,522)
Net cash used in financing activities	(1,532)	(136)
Net change in cash and cash equivalents	277	(144)
Cash and cash equivalents at beginning of period	184	509
Cash and cash equivalents at end of period	461	365
Parent Company [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(5)	(14)
Cash flows from financing activities:
Proceeds from exercise of stock options		22
Repurchase of restricted stock shares for payroll tax withholding requirements	(5)	(20)
Changes in intercompany balances with affiliates, net	10	12
Net cash used in financing activities	5	14
Issuer [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	(294)	(81)
Cash flows from investing activities:
Distribution from Quorum Health Corporation	1,219
Net cash provided by (used in) investing activities	1,219
Cash flows from financing activities:
Deferred financing costs and other debt-related costs	(22)	(30)
Changes in intercompany balances with affiliates, net	497	137
Borrowings under credit agreements	2,783	2,355
Repayments of long-term indebtedness	(4,183)	(2,381)
Net cash used in financing activities	(925)	81
Other Guarantor [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	599	242
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(3)	(20)
Purchases of property and equipment	(282)	(338)
Proceeds from disposition of hospitals and other ancillary operations	8	4
Proceeds from sale of property and equipment	4	5
Purchases of available-for-sale securities	(21)	(32)
Proceeds from sales of available-for-sale securities	14	30
Proceeds from the sale of investments in unconsolidated affiliates	403
Increase in other investments	(84)	(57)
Net cash provided by (used in) investing activities	39	(408)
Cash flows from financing activities:
Changes in intercompany balances with affiliates, net	(469)	(26)
Borrowings under credit agreements	2	30
Repayments of long-term indebtedness	(25)	(19)
Net cash used in financing activities	(492)	(15)
Net change in cash and cash equivalents	146	(181)
Cash and cash equivalents at beginning of period	32	373
Cash and cash equivalents at end of period	178	192
Non-Guarantor Subsidiaries [Member]
Cash flows from operating activities:
Net cash (used in) provided by operating activities	332	357
Cash flows from investing activities:
Acquisitions of facilities and other related equipment	(111)	(7)
Purchases of property and equipment	(125)	(136)
Proceeds from disposition of hospitals and other ancillary operations	4	58
Proceeds from sale of property and equipment	3	6
Purchases of available-for-sale securities	(42)	(58)
Proceeds from sales of available-for-sale securities	219	56
Increase in other investments	(29)	(23)
Net cash provided by (used in) investing activities	(81)	(104)
Cash flows from financing activities:
Redemption of noncontrolling investments in joint ventures	(16)	(14)
Distributions to noncontrolling investors in joint ventures	(47)	(48)
Changes in intercompany balances with affiliates, net	(38)	(123)
Borrowings under credit agreements	21
Proceeds from receivables facility	31	91
Repayments of long-term indebtedness	(71)	(122)
Net cash used in financing activities	(120)	(216)
Net change in cash and cash equivalents	131	37
Cash and cash equivalents at beginning of period	152	136
Cash and cash equivalents at end of period	$ 283	$ 173